CIK 0001590560
- Large accelerated filer
uniQure N.V.
Sign in to watch- Ticker
- QURE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +1 339-970-7000
- Business address
- PAASHEUVELWEG 25A, AMSTERDAM, Netherlands, 1105 BP
- Former names
- uniQure B.V.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $192,950
- in 1 filing, $193K under 10b5-1 plans
Net −$192,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-11 | Springhorn Jeremy P. Director | Grant or award · Stock Option (Right to Buy) | +15,630 | 15,630 | ||
| 2025-06-11 | Meek David D. Director | Grant or award | +7,970 | 36,302 | ||
| 2025-06-11 | Meek David D. Director | Grant or award · Stock Option (Right to Buy) | +15,630 | 15,630 | ||
| 2025-03-04 | Kapusta Matthew C CEO, Managing Director | Sale | −28,341 | $10.29 | $292K | 651,454 |
| 2025-03-04 | Abi-Saab Walid Chief Medical Officer | Sale | −1,350 | $10.29 | $14K | 151,903 |
| 2025-03-04 | KLEMT CHRISTIAN Chief Financial Officer | Sale | −10,438 | $10.29 | $107K | 217,730 |
| 2025-03-04 | Potts Jeannette Chief Legal Officer | Sale | −7,076 | $10.29 | $73K | 119,743 |
| 2025-03-03 | Kapusta Matthew C CEO, Managing Director | Grant or award | +99,000 | 679,795 | ||
| 2025-03-03 | Kapusta Matthew C CEO, Managing Director | Grant or award · Stock Option (Right to Buy) | +171,000 | 171,000 | ||
| 2025-03-03 | Abi-Saab Walid Chief Medical Officer | Grant or award | +38,000 | 153,253 | ||
| 2025-03-03 | Abi-Saab Walid Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +66,000 | 66,000 | ||
| 2025-03-03 | KLEMT CHRISTIAN Chief Financial Officer | Grant or award | +73,000 | 228,168 | ||
| 2025-03-03 | KLEMT CHRISTIAN Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +126,000 | 126,000 | ||
| 2025-03-03 | Potts Jeannette Chief Legal Officer | Grant or award | +35,000 | 126,819 | ||
| 2025-03-03 | Potts Jeannette Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2025-02-27 | Kapusta Matthew C CEO, Managing Director | Sale | −6,717 | $11.32 | $76K | 580,795 |
| 2025-02-27 | KLEMT CHRISTIAN Chief Financial Officer | Sale | −2,916 | $11.32 | $33K | 155,168 |
| 2025-02-26 | Kapusta Matthew C CEO, Managing Director | Grant or award | +16,324 | 587,512 | ||
| 2025-02-26 | KLEMT CHRISTIAN Chief Financial Officer | Grant or award | +5,712 | 158,084 | ||
| 2025-02-25 | Kapusta Matthew C CEO, Managing Director | Sale | −26,727 | $10.70 | $286K | 571,188 |
Page 9 of 13 · 251 trades